A number of studies have evaluated the effect of proton-pump inhibitors on the risk of recurrent bleeding in patients with bleeding peptic ulcers. 7–13 Some of the studies did not use endoscopic ...

Background: Immune checkpoint inhibitors (ICI) have transformed cancer treatment by improving prognosis across various malignancies, while proton pump inhibitors (PPI) are frequently prescribed as ...

Background: Immune checkpoint inhibitors (ICIs) have transformed the treatment of non-small cell lung cancer (NSCLC), though response variability remains a challenge. Emerging evidence suggests that ...

TOKYO, Jun 2, 2025--- Eisai Co., Ltd. announced today the launch of "Pariet S", which is highly effective in alleviating severe heartburn andstomach pain caused by gastric acid reflux, at ...

Hypersensitivity reactions induced by proton pump inhibitors (PPIs) represent a growing concern given the extensive use of these agents for managing acid-related disorders. Although PPIs are ...

There is widespread empiric prescription of proton-pump inhibitors (PPIs) to patients on clopidogrel and aspirin therapy. Adverse interactions are observed between PPIs and clopidogrel.

Prior epidemiologic results have suggested a possible association between chronic, long-term use of proton-pump inhibitors (PPIs) and excess risk for osteoporosis-related fractures (JW ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...